Sign in
4

Changes in Ownership

Contineum Therapeutics, Inc. Filed Acc 0001437749-24-036349

Chief Scientific Officer sold 1,010 shares at $16.02 ($16,177)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lorrain Daniel S. · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-11-25 Sale : show line 1 in the form 10b5-1 −1,010 $16.02 $16,177 168,562 D
Open-market sales · 1,010 sh · avg $16.02 · $16,177
Loading xslF345X05/rdgdoc.xml…